Clinical Trials Browser

Phase 2 × Completed × Aspirin × Clear all

NCT04184921 2026-02-03

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT04182100 2025-09-15

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Phase 2 Completed

29 enrolled 15 charts

Myeloproliferative Disorders, Polycythemia Vera

NCT03543683 2025-02-27

Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT04534218 2024-12-20

REPROGRAM-01

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

NCT00482261 2024-11-08

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Phase 2 Completed

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT03003325 2024-09-19

Low-PV

Phase 2 Completed

Polycythemia Vera

NCT04243122 2024-05-29

AIRPORT-MPN

Phase 2 Completed

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT00578721 2023-07-07

Trial of Aspirin and Arginine Restriction in Colorectal Cancer

Phase 2 Completed

24 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

NCT02659384 2023-03-14

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms

NCT03396952 2022-10-13

Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma

Phase 2 Completed

27 enrolled 13 charts

Melanoma

NCT04062032 2022-02-18

Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma

Phase 2 Completed

Melanoma

NCT04066725 2022-02-18

Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma

Phase 2 Completed

Melanoma

NCT03192059 2021-09-08

PRIMMO

Phase 2 Completed

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT02169271 2020-05-21

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

Phase 2 Completed

109 enrolled 27 charts

Tobacco Use Disorder, Smoking Cessation, Multiple Pulmonary Nodules

NCT00983580 2019-09-04

Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

Phase 2 Completed

107 enrolled 10 charts

Adenomatous Polyps

NCT02123849 2018-08-29

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

Phase 2 Completed

54 enrolled 15 charts

Lung Neoplasms, Tobacco Use Disorder

NCT00468910 2017-05-31

Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

Phase 2 Completed

79 enrolled 12 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms

NCT01259817 2017-01-11

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

Phase 2 Completed

Polycythemia Vera, Thrombocythemia, Essential

NCT00691704 2014-08-19

Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy

Phase 2 Completed

18 enrolled 12 charts

Multiple Myeloma

NCT00474903 2014-07-02

Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

Phase 2 Completed

122 enrolled 6 charts

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

NCT00020189 2013-06-19

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Thromboembolism